These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16417467)

  • 1. Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure.
    Cibrián D; Ajamieh H; Berlanga J; León OS; Alba JS; Kim MJ; Marchbank T; Boyle JJ; Freyre F; Garcia Del Barco D; Lopez-Saura P; Guillen G; Ghosh S; Goodlad RA; Playford RJ
    Clin Sci (Lond); 2006 May; 110(5):563-73. PubMed ID: 16417467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of epidermal growth factor plus growth hormone-releasing peptide-6 resembles hypothermia in experimental stroke.
    Subirós N; Pérez-Saad H; Aldana L; Gibson CL; Borgnakke WS; Garcia-Del-Barco D
    Neurol Res; 2016 Nov; 38(11):950-958. PubMed ID: 27665924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Catalina PF; Mallo F; Andrade MA; García-Mayor RV; Diéguez C
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3663-7. PubMed ID: 9768681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
    Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation.
    Yigiter M; Halici Z; Odabasoglu F; Keles ON; Atalay F; Unal B; Salman AB
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):94-100. PubMed ID: 21439711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine colostrum prevents bacterial translocation in an intestinal ischemia/reperfusion-injured rat model.
    Choi HS; Jung KH; Lee SC; Yim SV; Chung JH; Kim YW; Jeon WK; Hong HP; Ko YG; Kim CH; Jang KH; Kang SA
    J Med Food; 2009 Feb; 12(1):37-46. PubMed ID: 19298194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministration of epidermal growth factor and growth hormone releasing peptide-6 improves clinical recovery in experimental autoimmune encephalitis.
    del Barco DG; Montero E; Coro-Antich RM; Brown E; Suarez-Alba J; Lopez L; Subirós N; Berlanga J
    Restor Neurol Neurosci; 2011; 29(4):243-52. PubMed ID: 21697595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies in surgical trauma: oxidative stress in ischaemia-reperfusion of rat liver.
    Liu PT; Symons AM; Howarth JA; Boulter PS; Parke DV
    Clin Sci (Lond); 1994 Apr; 86(4):453-60. PubMed ID: 8168341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action of a second generation growth hormone-releasing peptide (Ala-His-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2) in rat anterior pituitary cells.
    Akman MS; Girard M; O'Brien LF; Ho AK; Chik CL
    Endocrinology; 1993 Mar; 132(3):1286-91. PubMed ID: 8095015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor reduces multiorgan failure induced by thioacetamide.
    Caballero ME; Berlanga J; Ramirez D; Lopez-Saura P; Gozalez R; Floyd DN; Marchbank T; Playford RJ
    Gut; 2001 Jan; 48(1):34-40. PubMed ID: 11115820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone.
    Bowers CY; Reynolds GA; Durham D; Barrera CM; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1990 Apr; 70(4):975-82. PubMed ID: 2108187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
    Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK
    J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of peripherally and centrally applied ghrelin in the pathogenesis of ischemia-reperfusion induced injury of the small intestine.
    Pawlik MW; Obuchowicz R; Biernat J; Szczepanski W; Pajdo R; Kwiecień S; Brzozowski T; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2011 Aug; 62(4):429-39. PubMed ID: 22100844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2 supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion.
    Anderson SM; Wideman L; Patrie JT; Weltman A; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5904-11. PubMed ID: 11739462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
    Anderson SM; Shah N; Evans WS; Patrie JT; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone.
    Bercu BB; Yang SW; Masuda R; Walker RF
    Endocrinology; 1992 May; 130(5):2579-86. PubMed ID: 1315249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.